Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
97 studies found for:    PDC
Show Display Options
Rank Status Study
1 Completed Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea
Condition: Dysmenorrhea
Intervention: Drug: PDC31
2 Recruiting The Impact of Surgical Technique on PDC
Condition: Tooth, Impacted
Interventions: Procedure: Closed surgical technique;   Procedure: Open surgical technique
3 Enrolling by invitation A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
Condition: Contact Dermatitis
Interventions: Drug: PDC-APB;   Drug: Placebo
4 Not yet recruiting Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells
Condition: Innate Immune Responses
Intervention: Biological: Blood Plasmacytoid dendritic cells (pDCs) absolute number
5 Completed
Has Results
A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression
Condition: Major Depressive Disorder
Interventions: Drug: PDC-1421;   Drug: Placebo
6 Completed A Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis
Condition: Erosive Gastritis
Interventions: Drug: PDC339;   Drug: Placebo
7 Completed Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients
Condition: Melanoma
Intervention: Biological: PDC or myDC
8 Completed A Phase II Clinical Study of PDC-748 in Patients With Acute Cough
Condition: Acute Cough
Intervention: Drug: PDC-748
9 Completed
Has Results
Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters
Conditions: Dementia;   Alzheimer Disease
Intervention: Behavioral: Partners in Dementia Care
10 Active, not recruiting myDC/pDC in Stage III Melanoma Patients
Condition: Melanoma
Interventions: Drug: A: myDC vaccination;   Drug: B: pDC vaccination;   Drug: C: combined myDC/pDC vaccination
11 Completed Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Interferon-beta 1b (Betaseron)
12 Not yet recruiting A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)
Condition: Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: PDC-1421 Capsule;   Drug: placebo
13 Recruiting C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH or pdC1INH
14 Recruiting A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: PDC-1421 Capsule;   Drug: placebo
15 Completed
Has Results
The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics
Condition: Asthma
Intervention: Drug: Aeroallergen
16 Recruiting Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients
Conditions: Prostatic Neoplasms;   Immunotherapy;   Dendritic Cells;   Vaccines
Interventions: Biological: mDC vaccination;   Biological: pDC vaccination;   Biological: mDC and pDC vaccination
17 Recruiting Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Other: Mobile Application Intervention;   Drug: Rivaroxaban
18 Recruiting Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies
Condition: Pyruvate Dehydrogenase Complex Deficiency Disease
Intervention: Other: No intervention
19 Recruiting SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN);   Acute Myeloid Leukemia
Intervention: Drug: SL-401
20 Recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
Conditions: Adult Acute Myeloid Leukemia in Remission;   Donor;   Early Relapse of Acute Myeloid Leukemia;   Late Relapse of Acute Myeloid Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Blastic Plasmacytoid Dendritic Cell Neoplasm
Interventions: Drug: cyclophosphamide;   Biological: Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes;   Other: laboratory biomarker analysis;   Biological: Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes;   Drug: Fludarabine Phosphate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.